Recombinant IL2RA (Basiliximab Biosimilar) antibody

Catalog No. ABIN7597537

The Chimeric Chimeric anti-IL2RA (Basiliximab Biosimilar) antibody is suitable to detect IL2RA (Basiliximab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL2RA (Basiliximab Biosimilar) antibody (ABIN7597537)

Target: IL2RA (Basiliximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This IL2RA (Basiliximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL2RA (Basiliximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Basiliximab Biosimilar Antibody

Specificity: IL2-RA, IL-2R subunit alpha, TAC antigen, IL-2-RA, p55, IL2RA, IL-2 receptor subunit alpha, Interleukin-2 receptor subunit alpha, CD25

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.09 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL2RA (Basiliximab Biosimilar)

Target: IL2RA (Basiliximab Biosimilar)

Alternative Name: Basiliximab Biosimilar

Target Type: Biosimilar

Background: IL2-RA, IL-2R subunit alpha, TAC antigen, IL-2-RA, p55, IL2RA, IL-2 receptor subunit alpha, Interleukin-2 receptor subunit alpha, CD25

UniProt: P01589

CAS-No: 179045-86-4